Beibing Di
Beibing Di publishes mostly in Cardiology and Cardiovascular Medicine, Electrical and Electronic Engineering and Surgery, on topics such as Advanced Glycation End Products research, Peroxisome Proliferator-Activated Receptors and Advanced Antenna and Metasurface Technologies.
- World rank
- #6,245,802 of 7,710,434 ranked researchers
- Rank in China
- #870,094 of 978,568
- Works
- 30
- Citations
- 267
- Citations per work
- 8.9
What does Beibing Di research?
Beibing Di's work is mostly in Medicine (28%), Engineering (18%), Biochemistry, Genetics and Molecular Biology (14%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1241.0%
- Health Sciences827.6%
- Medicine827.6%
- Physical Sciences517.6%
- Engineering517.6%
- Life Sciences413.8%
- 1Cardiology and Cardiovascular Medicine19% of their works
- 2Electrical and Electronic Engineering11% of their works
- 3Surgery9% of their works
- 4Clinical Biochemistry8% of their works
- 5Aerospace Engineering6% of their works
- 6Molecular Biology6% of their works
Research topics
- Advanced Glycation End Products research
- Peroxisome Proliferator-Activated Receptors
- Advanced Antenna and Metasurface Technologies
- Advanced Wireless Communication Technologies
- Cardiac Arrhythmias and Treatments
- Cardiovascular Disease and Adiposity
- Cardiovascular, Neuropeptides, and Oxidative Stress Research
- Neuropeptides and Animal Physiology
Which keywords describe Beibing Di's research?
The keywords of their largest research topics: Inflammation, Diabetes, Obesity, Advanced Glycation End Products, Atherosclerosis, Cardiovascular Disease, HMGB1 and Peroxisome Proliferator-Activated Receptors.
- Neuropeptides
- Ventricular Tachycardia
- Urotensin II
- Metasurfaces
- Frequency Selective Surfaces
- Catheter Ablation
- PPARs
- Cardiovascular Disease
- Advanced Glycation End Products
- Diabetes
- Inflammation
- Obesity
- Atherosclerosis
- HMGB1
- Peroxisome Proliferator-Activated Receptors
- Epicardial Fat
- Intelligent Reflecting Surfaces
- Perivascular Adipose Tissue
- Vasoconstriction
- Wireless Communication
- Receptors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 21 words, with their numbers
- Inflammation143 topics
- Diabetes112 topics
- Obesity82 topics
- Advanced Glycation End Products61 topic
- Atherosclerosis62 topics
- Cardiovascular Disease62 topics
- HMGB161 topic
- PPARs51 topic
- Peroxisome Proliferator-Activated Receptors51 topic
- Catheter Ablation31 topic
- Epicardial Fat31 topic
- Frequency Selective Surfaces31 topic
- Intelligent Reflecting Surfaces31 topic
- Metasurfaces31 topic
- Perivascular Adipose Tissue31 topic
- Urotensin II31 topic
- Vasoconstriction31 topic
- Ventricular Tachycardia31 topic
- Wireless Communication31 topic
- Neuropeptides21 topic
- Receptors21 topic
Where does Beibing Di work?
Beibing Di's main affiliation in the publication record is Beijing Friendship Hospital, China.
How many publications and citations does Beibing Di have?
OpenAlex counts 30 works and 267 citations for Beibing Di, an h-index of 11, ranking #6,245,802 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Beibing Di. Posts are plain text and can be reported.